An investigation of the effects of nanosize delivery system for antisense oligonucleotide on esophageal squamous cancer cells

Cancer Biology and Therapy

Volumn 7, Issue 11, 2008, Pages 1852-1859

  Li, Huixiang ^a   Wang, Jin ^a   Zhou, Tianyang ^a   Zhang, Yingge ^b   Zhang, Zhenzhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Antisense oligonucleotide; Esophageal squamous cancer cells; hTERT; Nanosize delivery system

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ASPARAGINYLGLYCINYLARGININE; NANOCARRIER; PEPTIDE; POLYCATION; POLYETHYLENEIMINE; PROTON; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; NANOPARTICLE; OLIGONUCLEOTIDE; TELOMERASE; TERT PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; DRUG UPTAKE; ESOPHAGUS CARCINOMA; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TUMOR VASCULARIZATION; ULTRASTRUCTURE; ANIMAL; CHEMISTRY; ESOPHAGUS TUMOR; GENE THERAPY; GENETICS; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; NUDE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE THERAPY; HUMANS; MICE; MICE, NUDE; NANOPARTICLES; NANOTECHNOLOGY; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 56449121983     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.11.6879     Document Type: Article

References (22)

1. Akhtar S, HM, Khan A, Bibby M, Hussain M, Nawaz Q, et al. The delivery of antisense therapeutics. Adv Drug Deliv Rev 2000; 44:3-21.
2. Bohm I, TF, Block W, Schild H. Molecular imaging of apoptosis and necrosis - basic principles of cell biology and use in oncology. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2006; 178:263-71.
3. Boussif O, LHF, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci 1995; 92:7297-301.
4. Cong YS, WW, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002; 66:407-25.
5. Corti A, PM. Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs. Ann N Y Acad Sci 2004; 1028:104-12.
6. Curnis F, AG, Sacchi A, Fischetti L, Arap W, Pasqualini R, et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia and myeloid cells. Cancer Res 2002; 62:867-74.
7. Curnis F, SA, Borgna L, Magni F, Gasparri A, Corti A. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol 2000; 18:1185-90.
8. Fischer D, OB, Petersen H, Kissel T, Bickel U. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. Drug Metab Dispos 2004; 32:983-92.
9. Gao XD, CY. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells. Chin Med J 2007; 120:755-60.
10. Hisayasu S, MM, Akiyama K, Gotoh T, Satoh S, Shimada T. In vivo targeted gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D-serine copolymer. Gene Ther 1999; 6:689-93.
11. Huerta S, GE. Livingston EH. Colon cancer and apoptosis. Am J Surg 2006; 191:517-26.
12. Kraemer K, FS, Schmidt U, Kotzsch M, Schwenzer B, Wirth MP, et al. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res 2003; 9:3794-800.
13. Kyo S, KT, Takakura M, Tanaka M, Yamashita A, Inoue H, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 1999; 80:804-9.
14. Mao HQ, RK, Troung-le VL, Janes KA, Lin KY, Wang Y, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70:399-421.
15. Moffatt S, CR. Uptake characteristics of NGR-coupled stealth PEI/pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dendritic cells. Int J Pharm 2006; 321:143-54.
16. Moffatt S, WS, Cristiano RJ. Tumor-specific gene delivery mediated by a novel peptide-polyethylenimine-DNA polyplex targeting aminopeptidase N/CD13. Hum Gene Ther 2005; 16:57-67.
17. Shay JW, BS. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33:787-91.
18. Tamm I, DB, Hartmann G. Antisense therapy in oncology: new hope for an old idea? Lancet 2001; 358:489-97.
19. Vinogradov SV, BE, Li S, Kabanov AV. Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J Drug Target 2004; 12:517-26.
20. Xenariou S, GU, Liang HD, Zhu J, Farley R, Somerton L, et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther 2007; 14:768-74.
21. Zhang YY, FC, Zhang ZZ. Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA. Acta pharmaceutica Sinica 2006; 41:446-51.
22. Zhang Z, WB, Li H, Zhou T, Zhang L. The inhibitory effects of nanosize delivery system for antisense oligonucleotide of hTERT on EC9706 cells. Cancer Biol Ther 2007; 6:329-34.